| A4021020 | Closed to Recruitment | A phase 1/phase 2 study of CP-751,871 in patients with relapsed and/or refractory Ewing’s Sarcoma Family of Tumours | Ewing’s Sarcoma | |
| Axi-STS study | Recruiting | A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas | Angiosarcoma, soft tissue sarcomas | Click here |
| BODIS | Recruiting | Quantifying Disease Burden in patients with sarcoma by monitoring tumour-specific genomic rearrangements | Osteosarcoma | |
| CAMN107G2301 | Closed to Recruitment | A randomized, open-label, multi-centre phase III study to evaluate the efficacy and safety of nilotinib vs imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumours (GIST) | GIST | |
| CASPS | In Set-Up | A Phase II Trial of Cedirinib in the Treatment of Patients with Alveolar Soft Part Sarcoma | Alveolar Soft Part Sarcoma | Click here |
| EuroEwing 99 | Recruiting | European Ewing Tumour Working Initiatives National Group: Ewing Tumour Studies 1999 | Ewing’s Sarcoma | Click here |
| EORTC 62024 | Closed to Recruitment | Intermediate and high risk localised completely resected gastrointestinal stromal tumours (GIST) expressing KIT receptor: A controlled randomised trial of adjuvant Imatinib Mesylate (Glivec) versus no further therapy after complete surgery. | GIST | Click here |
| EPPSSG RMS2005 | Recruiting | Study of the treatment of rhabdomyosarcoma in childhood and adolescence | rhabdomyosarcoma | Click here |
| EURAMOS 1 | Closed to Recruitment | A Randomised Trial of the European and American Osteosarcoma Study Group to Optimise Treatment Strategies for Resectable Osteosarcoma Based on Histological response to Pre-operative Chemotherapy | Osteosarcoma | Click here |
| GeDDiS | Recruiting | A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas | Soft Tissue Sarcoma | Click here |
| GLU-1 | Recruiting | A randomised, cross-over, phase II study, to investigate the efficacy and safety of glucarpidase for routine use after high dose methotrexate in patients with bone sarcoma | Osteosarcoma | Click here |
| Infinity IPI-926-04 (Hedgehog) | Recruiting | A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of IPI-926 in Patients with Metastatic or Locally advanced (unresectable) Chondrosarcoma | Chondrosarcoma | |
| OTIS | Recruiting | Oral Treosulfan in Ewing’s Sarcoma: A Phase II Study to determine the efficacy and safety of conventional dose oral Treosulfan in patients with advanced pre-treated Ewing’s Sarcoma. | Ewing’s Sarcoma | Click here |
| P04720 | Closed to Recruitment | A study to determine the activity of SCH 717454 in subjects with Osteosarcoma or Ewing’s Sarcoma that has relapsed after standard systemic therapy. | Ewing’s Sarcoma, Osteosarcoma | |
| Pfizer A6181036/SUGEN | Closed to Recruitment | A treatment protocol for patients with gastrointestinal stromal tumour who are ineligible for participation in other SU011248 protocols and are refractory to or intolerant of imatinib mesylate | GIST | |
| SARC011 | Closed to Recruitment | SARC Global Collaboration: A phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor for the treatment of patients with recurrent or refractory Ewing’s Sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas | Ewing’s Sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas | |
| EORTC 62092 (STRASS) | In Set-Up | A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with Retroperitoneal sarcoma (RPS) | Retroperitoneal sarcoma | |
| SUCCEED | Closed to Recruitment | A pivotal trial to determine the efficacy and safety of AP23573 when administered as maintenance therapy to patients with metastatic soft tissue or bone sarcomas. | Soft Tissue Sarcoma, Bone Sarcoma | |
| VORTEX | Recruiting | VORTEX Randomised trial evaluating impact of changes in dose & amp; volume of postoperative radiotherapy on morbidity and limb function in adult patients with extremity soft tissue sarcoma | Soft Tissue Sarcoma | Click here |